Horrevorts AM - Search Results

1

Ecology of Pseudomonas aeruginosa in patients with cystic fibrosis.

Horrevorts AM, Borst J, Puyk RJ, De Ridder R, Dzoljicdanilovic G, Degener JE, Kerrebijn KF, Michel MF. Horrevorts AM, et al. J Med Microbiol. 1990 Feb;31(2):119-24. doi: 10.1099/00222615-31-2-119. J Med Microbiol. 1990. PMID: 2106033

2

Tobramycin in patients with cystic fibrosis. Adjustment in dosing interval for effective treatment.

Horrevorts AM, de Witte J, Degener JE, Dzoljic-Danilovic G, Hop WC, Driessen O, Michel MF, Kerrebijn KF. Horrevorts AM, et al. Chest. 1987 Nov;92(5):844-8. doi: 10.1378/chest.92.5.844. Chest. 1987. PMID: 3665599

3

Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Aminoglycoside antibiotics.

Horrevorts AM, Driessen OM, Michel MF, Kerrebijn KF. Horrevorts AM, et al. Chest. 1988 Aug;94(2 Suppl):120S-125S. Chest. 1988. PMID: 3293937 Review.

4

Pharmacokinetics of tobramycin in patients with cystic fibrosis. Implications for the dosing interval.

Horrevorts AM, Degener JE, Dzoljic-Danilovic G, Michel MF, Kerrebijn KF, Driessen O, Hermans J. Horrevorts AM, et al. Chest. 1985 Aug;88(2):260-4. doi: 10.1378/chest.88.2.260. Chest. 1985. PMID: 4017681

5

Endemic acinetobacter in intensive care units: epidemiology and clinical impact.

Dijkshoorn L, van Dalen R, van Ooyen A, Bijl D, Tjernberg I, Michel MF, Horrevorts AM. Dijkshoorn L, et al. Among authors: horrevorts am. J Clin Pathol. 1993 Jun;46(6):533-6. doi: 10.1136/jcp.46.6.533. J Clin Pathol. 1993. PMID: 8331175 Free PMC article.

6

Antibiotic interaction: interpretation of fractional inhibitory and fractional bactericidal concentration indices.

Horrevorts AM, Michel MF, Kerrebijn KF. Horrevorts AM, et al. Eur J Clin Microbiol. 1987 Aug;6(4):502-3. doi: 10.1007/BF02013128. Eur J Clin Microbiol. 1987. PMID: 3665908 No abstract available.

7

Emergence of antibiotic resistance amongst Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Mouton JW, den Hollander JG, Horrevorts AM. Mouton JW, et al. Among authors: horrevorts am. J Antimicrob Chemother. 1993 Jun;31(6):919-26. doi: 10.1093/jac/31.6.919. J Antimicrob Chemother. 1993. PMID: 8360129

8

Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers.

Mouton JW, Horrevorts AM, Mulder PG, Prens EP, Michel MF. Mouton JW, et al. Among authors: horrevorts am. Antimicrob Agents Chemother. 1990 Dec;34(12):2307-11. doi: 10.1128/AAC.34.12.2307. Antimicrob Agents Chemother. 1990. PMID: 2088186 Free PMC article.

9

[The treatment of cystic fibrosis].

de Jongste JC, Neijens HJ, Duiverman EJ, Horrevorts AM, Sinaasappel M, Kerrebijn KF. de Jongste JC, et al. Among authors: horrevorts am. Ned Tijdschr Geneeskd. 1986 Feb 15;130(7):297-301. Ned Tijdschr Geneeskd. 1986. PMID: 3485258 Dutch. No abstract available.

10

Chequerboard titrations: the influence of the composition of serial dilutions of antibiotics on the fractional inhibitory concentration index and fractional bactericidal concentration index.

Horrevorts AM, de Ridder CM, Poot MC, de Jonge MJ, Degener JE, Dzoljic-Danilovic G, Michel MF, Kerrebijn KF. Horrevorts AM, et al. J Antimicrob Chemother. 1987 Jan;19(1):119-25. doi: 10.1093/jac/19.1.119. J Antimicrob Chemother. 1987. PMID: 3104274

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters